Early characterization and prediction of glioblastoma and brain metastasis treatment efficacy using medical imaging-based radiomics and artificial intelligence algorithms
Among brain tumors, glioblastoma (GBM) is the most common and the most aggressive type, and brain metastases (BMs) occur in 20%–40% of cancer patients. Even with intensive treatment involving radiotherapy and surgery, which frequently leads to cognitive decline due to doses on healthy brain tissue,...
Saved in:
Main Authors: | Noémie N. Moreau, Samuel Valable, Cyril Jaudet, Loïse Dessoude, Leleu Thomas, Romain Hérault, Romain Modzelewski, Dinu Stefan, Juliette Thariat, Alexis Lechervy, Aurélien Corroyer-Dulmont |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1497195/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and routine implementation of deep learning algorithm for automatic brain metastases segmentation on MRI for RANO-BM criteria follow-up
by: Loïse Dessoude, et al.
Published: (2025-02-01) -
Drug Efficacy Recommendation System of Glioblastoma (GBM) Using Deep Learning
by: Sajid Naveed, et al.
Published: (2025-01-01) -
Distinguishing glioblastoma from brain metastasis; a systematic review and meta-analysis on the performance of machine learning
by: Mohammad Amin Habibi, et al.
Published: (2025-02-01) -
Early growth response 1 transcription factor and its context-dependent functions in glioblastoma
by: Saleh Rasras, et al.
Published: (2024-08-01) -
High p16INK4A expression in glioblastoma is associated with senescence phenotype and better prognosis
by: Soon Sang Park, et al.
Published: (2025-02-01)